Core products key to solid first half at UCB
This article was originally published in Scrip
Executive Summary
Solid growth from core products Cimzia, Vimpat and Neupro helped UCB increase revenue in the first half of the year by 3% to €1.6 billion. The Belgian company reiterated its financial guidance for the full year 2010, saying it expects to achieve total annual revenue of around €3.0 billion.